ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting
ImprimisRx announced its participation at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held at the San Diego Convention Center in San Diego, May 3-7, 2019.
At the conference, attendees will have the opportunity to meet with ImprimisRx representatives at Exhibit #1427 to learn more about new ImprimisRx proprietary formulations launching this year, including:
- Klarity-A Drops (preservative-free ophthalmic solution + azithromycin 1%)
- Klarity-B Drops (preservative-free ophthalmic solution + betamethasone 0.1%)
- Klarity-L Drops (preservative-free ophthalmic solution + loteprednol 0.5%)
- LessDrops formulations with moxifloxacin
- Povidone Iodine 5%
There will be a combination of eleven relevant physician presentations or posters, which will touch on all five ImprimisRx portfolios: Dropless, LessDrops, Simple Drops, Total Tears, and IV Free. Additionally, ImprimisRx is hosting an open house at the Hard Rock Hotel in downtown San Diego from 5:30-7:30pm on Saturday May 4th, where anyone registered can learn more about the robust portfolio of ophthalmic compound medications offered by ImprimisRx. Please register by clicking here if you have an interest in attending the open house.
“We are excited to have our largest presence ever at ASCRS, where paper presentations, posters, speakers, and an instructional course will detail the value proposition of our unique portfolio,” John Saharek, President of ImprimisRx, said in a company news release. “ImprimisRx is also announcing the launch of a number of new ophthalmology-focused innovative compounded formulations, some of which represent completely new markets for us. Our team is excited to update the ophthalmic community on our unique offerings which we believe address unmet needs. We look forward to visiting with customers and shareholders alike at Exhibit #1427.”